Holen Sie sich die Stockscreener-App
6.76
16.35%
0.95
Erasca Inc Aktie (ERAS) Neueste Nachrichten
Erasca Stock Surges as Market Eyes Revolution Medicines Acquisition - StocksToTrade
Analyst Confidence High in Erasca (ERAS) Amid Pipeline Advancement and Earlier Q3 2025 Results - MSN
Why Erasca Inc. stock could be next big winnerJuly 2025 Levels & Low Risk Investment Opportunities - ulpravda.ru
Ebun Garner Sells 120,000 Shares of Erasca (NASDAQ:ERAS) Stock - Defense World
Erasca (NASDAQ:ERAS) Earns Overweight Rating from Analysts at Piper Sandler - Defense World
Erasca price target raised to $6 from $4 at Stifel - MSN
Erasca Stock Surges Amid Merger Talks and Positive Analyst Ratings - StocksToTrade
Erasca Inc. (ERAS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Erasca Inc. stock appeals to analystsEarnings Growth Report & Weekly High Potential Stock Alerts - ulpravda.ru
Risk Analysis: Why Erasca Inc stock is favored by pension fundsNew Guidance & Proven Capital Preservation Tips - moha.gov.vn
Immuneering, Phathom Pharmaceuticals, Canadian Solar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Sahm
Erasca’s general counsel Garner sells $670,812 in shares By Investing.com - Investing.com India
ERAS Insider Trading - Quiver Quantitative
Erasca’s general counsel Garner sells $670,812 in shares - Investing.com
Assessing Erasca (ERAS) Valuation After FDA Trial Hold And New ERAS-0015 Patent - simplywall.st
How geopolitical tensions affect Erasca Inc. stockTrend Reversal & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
Rate Cut: How Erasca Inc. stock responds to policy changesPortfolio Gains Report & Smart Swing Trading Alerts - ulpravda.ru
Is Erasca Inc. stock a buy for dividend growth2025 Volatility Report & Low Risk Investment Opportunities - ulpravda.ru
What's Going With Cancer Biotech Erasca Stock On Thursday? - Benzinga
Erasca price target raised to $2 from $1 at BofA - MSN
Erasca Stock Pre-Market (-14%) : FDA Places Partial Clinical Hold on ERAS-4001 Trial - Trefis
What's Happening With Cancer Biotech Erasca Shares This Thursday? - Bitget
Erasca up 66% after WSJ report on AbbVie interest in Revolution Medicines - TipRanks
Erasca stock pulls back after 25% jump, Stifel cites competitor data By Investing.com - Investing.com Canada
Erasca stock pulls back after 25% jump, Stifel cites competitor data - Investing.com India
Erasca Inc stock hits 52-week high at $3.80 - Investing.com
Erasca Inc stock hits 52-week high at $3.80 By Investing.com - Investing.com Nigeria
Piper Sandler Initiates Erasca at Overweight With $5 Price Target - MarketScreener
Piper Sandler initiates Erasca stock with Overweight rating, $5 price target - Investing.com Nigeria
User | custercountychief.comErasca, Inc.Common Stock (Nasdaq:ERAS) Stock Quote - FinancialContent
Piper Sandler initiates Erasca stock with Overweight rating, $5 price target By Investing.com - Investing.com South Africa
Erasca initiated with an Overweight at Piper Sandler - TipRanks
Piper Sandler initiates coverage of Erasca (ERAS) with overweight recommendation - MSN
Upcoming EventsErasca, Inc.Common Stock (Nasdaq:ERAS) Stock Quote - FinancialContent
Down -25.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Erasca (ERAS) - MSN
BPASErasca, Inc.Common Stock (Nasdaq:ERAS) Stock Quote - FinancialContent
Erasca to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
B of A Securities Upgrades Erasca (ERAS) - MSN
Fund Flows: How geopolitical tensions affect Erasca Inc stock2025 Market Sentiment & Real-Time Price Movement Reports - moha.gov.vn
Erasca (NASDAQ:ERAS) Trading Up 4.1% – Should You Buy? - Defense World
Aug Spikes: How Erasca Inc stock responds to policy changesJuly 2025 Drop Watch & Low Risk Growth Stock Ideas - moha.gov.vn
Erasca (ERAS) Valuation Check After S&P Biotechnology Select Industry Index Inclusion - Yahoo Finance
Did Index Inclusion and New RAS Patent Just Shift Erasca's (ERAS) Investment Narrative? - simplywall.st
Are Erasca Inc (ERAS) shares a good deal now? - uspostnews.com
Erasca, Inc.(NasdaqGS: ERAS) added to S&P Biotechnology Select Industry Index - marketscreener.com
Treasury Yields: Is Erasca Inc stock a buy on dipsWeekly Profit Summary & AI Powered Market Entry Strategies - moha.gov.vn
Will Erasca Inc. stock remain a Wall Street favoritePortfolio Update Summary & Risk Controlled Swing Trade Alerts - Улправда
Buyback Watch: Is Erasca Inc. stock a buy on dipsMarket Activity Summary & Daily Chart Pattern Signals - DonanımHaber
Aug Weekly: How Erasca Inc. stock responds to policy changesJuly 2025 Momentum & Free Long-Term Investment Growth Plans - DonanımHaber
Momentum Shift: Why Erasca Inc. stock could be next big winner2025 Geopolitical Influence & Comprehensive Market Scan Reports - Улправда
Erasca (ERAS) Valuation Check After ERAS-0015 Patent Extension and New Chief Scientific Officer Appointment - simplywall.st
Erasca Inc stock hits 52-week high at $3.68 - Investing.com India
Shareholder Erasca Foundation Files To Sell 8,333 Of Erasca Inc [ERAS] - TradingView — Track All Markets
Erasca Inc stock hits 52-week high at $3.68 By Investing.com - Investing.com Nigeria
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):